Rezultati - Wang, Aoli

Comparative Analysis of Adelphocoris suturalis Jakovlev (Hemiptera: Miridae) Immune Responses to Fungal and Bacterial Pathogens od Ma, Meiqi, Guo, Libin, Tu, Chengjie, Wang, Aoli, Xu, Letian, Luo, Jing

Polni tekst Polni tekst Polni tekst

Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma od Liu, Juan, Liang, Qianmao, Wang, Aoli, Zou, Fengming, Qi, Ziping, Yu, Kailin, Liu, Qingwang, Chen, Cheng, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia od Hu, Chen, Zou, Fengming, Wang, Aoli, Miao, Weili, Liang, Qianmao, Weisberg, Ellen L., Wang, Yinsheng, Liu, Jing, Wang, Wenchao, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity od He, Hongbin, Jiang, Hua, Chen, Yun, Ye, Jin, Wang, Aoli, Wang, Chao, Liu, Qingsong, Liang, Gaolin, Deng, Xianming, Jiang, Wei, Zhou, Rongbin

Polni tekst Polni tekst Polni tekst

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders od Jiang, Hua, He, Hongbin, Chen, Yun, Huang, Wei, Cheng, Jinbo, Ye, Jin, Wang, Aoli, Tao, Jinhui, Wang, Chao, Liu, Qingsong, Jin, Tengchuan, Jiang, Wei, Deng, Xianming, Zhou, Rongbin

Polni tekst Polni tekst Polni tekst

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent od Jiang, Zongru, Wang, Li, Liu, Xuesong, Chen, Cheng, Wang, Beilei, Wang, Wenliang, Hu, Chen, Yu, Kailin, Qi, Ziping, Liu, Qingwang, Wang, Aoli, Liu, Jing, Hong, Guangchen, Wang, Wenchao, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours od Liu, Juan, Gao, Jingjing, Wang, Aoli, Jiang, Zongru, Qi, Shuang, Qi, Ziping, Liu, Feiyang, Yu, Kailin, Cao, Jiangyan, Chen, Cheng, Hu, Chen, Wu, Hong, Wang, Li, Wang, Wenchao, Liu, Qingsong, Liu, Jing

Polni tekst Polni tekst Polni tekst

Ibrutinib Selectively Targets FLT3-ITD in Mutant FLT3-Positive AML od Wu, Hong, Hu, Chen, Wang, Aoli, Weisberg, Ellen L., Wang, Wenchao, Chen, Cheng, Zhao, Zheng, Yu, Kailin, Liu, Juan, Wu, Jiaxin, Nonami, Atsushi, Wang, Li, Wang, Beilei, Stone, Richard M., Liu, Suiyang, Griffin, James D., Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia od Wang, Aoli, Hu, Chen, Chen, Cheng, Liang, Xiaofei, Wang, Beilei, Zou, Fengming, Yu, Kailin, Li, Feng, Liu, Qingwang, Qi, Ziping, Wang, Junjie, Wang, Wenliang, Wang, Li, Weisberg, Ellen L., Wang, Wenchao, Li, Lili, Ge, Jian, Xia, Ruixiang, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode od Hu, Chen, Wang, Aoli, Wu, Hong, Qi, Ziping, Li, Xixiang, Yan, Xiao-E, Chen, Cheng, Yu, Kailin, Zou, Fengming, Wang, Wenchao, Wang, Wei, Wu, Jiaxin, Liu, Juan, Wang, Beilei, Wang, Li, Ren, Tao, Zhang, Shanchun, Yun, Cai-Hong, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs) od Yu, Kailin, Liu, Xuesong, Jiang, Zongru, Hu, Chen, Zou, Fengming, Chen, Cheng, Ge, Juan, Wu, Jiaxin, Liu, Xiaochuan, Wang, Aoli, Wang, Wenliang, Wang, Wenchao, Qi, Ziping, Wang, Beilei, Wang, Li, Yan, Hezhong, Wang, Jiaoxue, Ren, Tao, Tang, Jun, Liu, Qingsong, Liu, Jing

Polni tekst Polni tekst Polni tekst

Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia... od Wu, Jiaxin, Wang, Aoli, Li, Xixiang, Chen, Cheng, Qi, Ziping, Hu, Chen, Wang, Wenliang, Wu, Hong, Huang, Tao, Zhao, Ming, Wang, Wenchao, Hu, Zhenquan, Liu, Qingwang, Wang, Beilei, Wang, Li, Li, Lili, Ge, Jian, Ren, Tao, Xia, Ruixiang, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation od Wang, Aoli, Yan, Xiao-E, Wu, Hong, Wang, Wenchao, Hu, Chen, Chen, Cheng, Zhao, Zheng, Zhao, Peng, Li, Xixiang, Wang, Li, Wang, Beilei, Ye, Zi, Wang, Jinhua, Wang, Chu, Zhang, Wei, Gray, Nathanael S., Weisberg, Ellen L., Chen, Liang, Liu, Jing, Yun, Cai-Hong, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model od Wu, Hong, Huang, Qiong, Qi, Ziping, Chen, Yongfei, Wang, Aoli, Chen, Cheng, Liang, Qianmao, Wang, Jinghua, Chen, Wensheng, Dong, Jin, Yu, Kailin, Hu, Chen, Wang, Wenchao, Liu, Xiaochuan, Deng, Yuanxin, Wang, Li, Wang, Beilei, Li, Xiaoxiang, Gray, Nathanael S., Liu, Jing, Wei, Wei, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML od Wang, Aoli, Wu, Hong, Chen, Cheng, Hu, Chen, Qi, Ziping, Wang, Wenchao, Yu, Kailin, Liu, Xiaochuan, Zou, Fengming, Zhao, Zheng, Wu, Jiaxin, Liu, Juan, Liu, Feiyang, Wang, Li, Stone, Richard M., Galinksy, Ilene A., Griffin, James D., Zhang, Shanchun, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML) od Liu, Feiyang, Wang, Beilei, Wang, Qiang, Qi, Ziping, Chen, Cheng, Kong, Lu-Lu, Chen, Ji-Yun, Liu, Xiaochuan, Wang, Aoli, Hu, Chen, Wang, Wenchao, Wang, Huiping, Wu, Fan, Ruan, Yanjie, Qi, Shuang, Liu, Juan, Zou, Fengming, Hu, Zhenquan, Wang, Wei, Wang, Li, Zhang, Shanchun, Yun, Cai-Hong, Zhai, Zhimin, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma od Wu, Hong, Wang, Wenchao, Liu, Feiyang, Weisberg, Ellen L., Tian, Bei, Chen, Yongfei, Li, Binhua, Wang, Aoli, Wang, Beilei, Zhao, Zheng, McMillin, Douglas W., Hu, Chen, Li, Hong, Wang, Jinhua, Liang, Yanke, Buhrlage, Sara J., Liang, Junting, Liu, Jing, Yang, Guang, Brown, Jennifer R., Treon, Steven P., Mitsiades, Constantine S., Griffin, James D., Liu, Qingsong, Gray, Nathanael S.

Polni tekst Polni tekst Polni tekst

Discovery of a Highly Potent FLT3 Kinase Inhibitor for FLT3-ITD-Positive AML od Wu, Hong, Wang, Aoli, Qi, Ziping, Li, Xixiang, Chen, Cheng, Yu, Kailin, Zou, Fengming, Hu, Chen, Wang, Wenchao, Zhao, Zheng, Wu, Jiaxin, Liu, Juan, liu, Xiaochuan, Wang, Li, Wang, Wei, Zhang, Shanchun, Stone, Richard M., Galinsky, Ilene A., Griffin, James D., Weinstock, David, Christodoulou, Alexandra, Wang, Huiping, Shen, Yuanyuan, Zhai, Zhimin, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances od Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Chen, Cheng, Liu, Juanjuan, Zhao, Zheng, Wu, Hong, Deng, Yuanxin, Wang, Li, Wang, Beilei, Wu, Jiaxin, Liu, Feiyang, Fernandes, Stacey M., Adamia, Sophia, Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Griffin, James D., Zhang, Shanchun, Loh, Teckpeng, Zhang, Xin, Wang, Wenchao, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies od Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Liu, Juanjuan, Zou, Fengming, Chen, Cheng, Zhao, Zheng, Deng, Yuanxin, Wu, Hong, Qi, Ziping, Wang, Beilei, Wang, Li, Liu, Feiyang, Xu, Yunhe, Wang, Wenchao, Fernandes, Stacey M., Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Loh, Teckpeng, Griffin, James. D., Zhang, Shanchun, Weisberg, Ellen L., Zhang, Xin, Liu, Jing, Liu, Qingsong

Polni tekst Polni tekst Polni tekst